Prescription Drug News and Research

RSS
Study examines impact of the elimination of preferred pharmacy networks on Medicare Part D program

Study examines impact of the elimination of preferred pharmacy networks on Medicare Part D program

First Edition: March 10, 2014

First Edition: March 10, 2014

Longer looks: Health care in jail; preventing Medicare drug fraud; new medical codes

Longer looks: Health care in jail; preventing Medicare drug fraud; new medical codes

Costs for medications expected to rise by 3 – 5% in all health care settings in 2014

Costs for medications expected to rise by 3 – 5% in all health care settings in 2014

Medicare drug program falls short in tracking fraud

Medicare drug program falls short in tracking fraud

Study finds significant reduction in hospital admissions with Medicare Part D prescription coverage

Study finds significant reduction in hospital admissions with Medicare Part D prescription coverage

Plan to revamp Medicare drug plans meets resistance

Plan to revamp Medicare drug plans meets resistance

First Edition: March 3, 2014

First Edition: March 3, 2014

Research roundup: Medicaid peer support; doctor Jokes; ACA's asset rules for coverage

Research roundup: Medicaid peer support; doctor Jokes; ACA's asset rules for coverage

Storytelling can help doctors recall opioid guidelines

Storytelling can help doctors recall opioid guidelines

Medicare Part D cost-saving plan draws opposition on several fronts

Medicare Part D cost-saving plan draws opposition on several fronts

First Edition: February 27, 2014

First Edition: February 27, 2014

Report: Spending on health care for children increased between 2009 and 2012

Report: Spending on health care for children increased between 2009 and 2012

Medicare official defends proposed changes to prescription drug program

Medicare official defends proposed changes to prescription drug program

Santalis Pharmaceuticals partners with TFS for marketing of OTC dermatology products

Santalis Pharmaceuticals partners with TFS for marketing of OTC dermatology products

Regeneron receives FDA acceptance for EYLEA injection for treatment of macular edema

Regeneron receives FDA acceptance for EYLEA injection for treatment of macular edema

New report reveals prevalence of heroin-related overdose deaths in Kentucky

New report reveals prevalence of heroin-related overdose deaths in Kentucky

GOP strategists prepare to pounce on Medicare advantage payment changes

GOP strategists prepare to pounce on Medicare advantage payment changes

Kindred Healthcare consolidated revenues decline 1% to $1.22 billion in Q4 2013

Kindred Healthcare consolidated revenues decline 1% to $1.22 billion in Q4 2013

IBM content analysis software helps identify patients at risk for developing heart failure

IBM content analysis software helps identify patients at risk for developing heart failure

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.